An open-label, non-comparative, non-interventional, multi-center, post-authorization safety study on the administration of rabeprazole to adults with gastro-esophageal reflux disease.

Autor: Zouboulis-Vafiadis, Irini1, Paraskevas, Emmanuel2, Tzourmakliotis, Dimitrios3, Hatzikyriakou, Maria4, Mestoussi, Angeliki4, Vasdekis, Vassilios5, Katsilabros, Nkolaos1, Arhimandritis, Athanasios6, Papadokostopoulou, Alexandra4 apapadok@its.jnj.com
Zdroj: Annals of Gastroenterology. 2014, Vol. 27 Issue 2, p133-138. 6p.
Databáze: Academic Search Ultimate